This program provides an overview of a treatment option for metastatic pancreatic cancer, advanced non-small cell lung cancer, and metastatic breast cancer. The topics covered include the recommended doses, dose modifications, safety and efficacy data from the pivotal studies, and other important product information.
This is a Celgene Corporation promotional activity. Seating is on a first-come, first-served basis. Please plan to arrive early to have the best chance at securing your seat.
